[ATRA] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[ATRA] Atara Biotherapeutics, Inc.
Announcement Date
28-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 87.91%
Quarter Report
ATRA's Result
ATRA's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 8,573 63,573 20,340 0 0 0 0 -
PBT -276,111 -228,290 -340,095 -306,605 -290,964 -230,743 -119,505 14.97%
Tax 15 12 46 15 12 -44 -14 -
NP -276,126 -2,283,020 -3,401,410 -3,066,200 -2,909,760 -2,306,990 -1,194,910 -21.65%
Tax Rate - - - - - - - -
Total Cost 284,699 2,346,593 3,421,750 3,066,200 2,909,760 2,306,990 1,194,910 -21.25%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -3,220.88 -3,591.18 -16,722.76 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -65.18 -55.96 -90.78 -103.63 -141.78 -131.64 -100.03 -6.88%
EPS Diluted -65.18 -55.96 -90.78 -103.63 -141.78 -131.64 -100.03 -6.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.